ZOLL Medical Corporation Wins Patent Infringement Case Against ELan Med GmbH

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the District Court of Munich, Germany, ruled in favor of ZOLL in granting an injunction against ELan Med GmbH of Cologne, Germany, for infringing on a ZOLL patent through the distribution and sale of certain ELan products for use with ZOLL’s Intravascular Temperature Management (IVTM™) systems. Under the terms of the judgment, ELan has been ordered to stop the manufacture and sale of infringing products for use with ZOLL’s patented temperature management systems (the Thermogard XP® and CoolGard 300® intravascular temperature management systems). The court also ruled that ZOLL is entitled to recover damages resulting from sales of the infringing products that were incurred since January 18, 2012, and ordered ELan to pay 90% of the cost of the court proceedings.

Back to news